CAMP FY 2020 Earnings — CAMP4 Therapeutics Corporation Revenue & Financial Results | Market Cap Arena

CAMPCAMP4 Therapeutics Corporation

$125M

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$309M-15.7% YoY

Gross Profit

$122M39.7% margin

Operating Income

-$4M-1.3% margin

Net Income

-$21M-6.9% margin

EPS (Diluted)

$-0.62

Cash Flow

Operating Cash Flow

$29M

Free Cash Flow

$17M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$442M

Total Liabilities

$343M

Stockholders' Equity

$99M

Cash & Equivalents

$92M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$309M	$366M	-15.7%
Gross Profit	$122M	$143M	-14.6%
Operating Income	-$4M	-$17M	+76.9%
Net Income	-$21M	-$79M	+73.1%